Cargando…
Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010015/ https://www.ncbi.nlm.nih.gov/pubmed/24829812 http://dx.doi.org/10.1155/2013/123134 |
_version_ | 1782479824234741760 |
---|---|
author | Powers, Braden Uppalapati, Aditya Gogineni, Sindhura Jamkhana, Zafar Akram |
author_facet | Powers, Braden Uppalapati, Aditya Gogineni, Sindhura Jamkhana, Zafar Akram |
author_sort | Powers, Braden |
collection | PubMed |
description | Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide was held secondary to complications of acute kidney injury, hematuria, and concern for a possible hemorrhagic cystitis. However, during the workup for hematuria the patient acutely developed respiratory failure and was found to have DAH. The patient was initially supported with mechanical ventilation volume control mode, steroids, and plasma exchange. With no improvement of oxygenation, the mode of ventilation was changed to airway pressure release ventilation (APRV) and the patient was started on rituximab. The patient clinically improved over the next few days, was able to be extubated, and was transferred out of the intensive care unit. |
format | Online Article Text |
id | pubmed-4010015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40100152014-05-14 Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis Powers, Braden Uppalapati, Aditya Gogineni, Sindhura Jamkhana, Zafar Akram Case Rep Crit Care Case Report Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide was held secondary to complications of acute kidney injury, hematuria, and concern for a possible hemorrhagic cystitis. However, during the workup for hematuria the patient acutely developed respiratory failure and was found to have DAH. The patient was initially supported with mechanical ventilation volume control mode, steroids, and plasma exchange. With no improvement of oxygenation, the mode of ventilation was changed to airway pressure release ventilation (APRV) and the patient was started on rituximab. The patient clinically improved over the next few days, was able to be extubated, and was transferred out of the intensive care unit. Hindawi Publishing Corporation 2013 2013-02-14 /pmc/articles/PMC4010015/ /pubmed/24829812 http://dx.doi.org/10.1155/2013/123134 Text en Copyright © 2013 Braden Powers et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Powers, Braden Uppalapati, Aditya Gogineni, Sindhura Jamkhana, Zafar Akram Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title | Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title_full | Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title_fullStr | Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title_full_unstemmed | Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title_short | Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis |
title_sort | rituximab—a drug with many facets and cures: a treatment for acute refractory hypoxemic respiratory failure secondary to severe granulomatosis with polyangiitis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010015/ https://www.ncbi.nlm.nih.gov/pubmed/24829812 http://dx.doi.org/10.1155/2013/123134 |
work_keys_str_mv | AT powersbraden rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis AT uppalapatiaditya rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis AT goginenisindhura rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis AT jamkhanazafarakram rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis |